Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 21;19(5):1526.
doi: 10.3390/ijms19051526.

Genomics of Fibromuscular Dysplasia

Affiliations
Review

Genomics of Fibromuscular Dysplasia

Silvia Di Monaco et al. Int J Mol Sci. .

Abstract

Fibromuscular Dysplasia (FMD) is &ldquo;an idiopathic, segmental, non-atherosclerotic and non-inflammatory disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries&rdquo; (Persu, et al; 2014). FMD can lead to hypertension, arterial dissections, subarachnoid haemorrhage, stroke or mesenteric ischemia. The pathophysiology of the disease remains elusive. While familial cases are rare (<5%) in contemporary FMD registries, there is evidence in favour of the existence of multiple genetic factors involved in this vascular disease. Recent collaborative efforts allowed the identification of a first genetic locus associated with FMD. This intronic variant located in the phosphatase and actin regulator 1 gene (PHACTR1) may influence the transcription activity of the endothelin-1 gene (EDN1) located nearby on chromosome 6. Interestingly, the PHACTR1 locus has also been involved in vascular hypertrophy in normal subjects, carotid dissection, migraine and coronary artery disease. National and international registries of FMD patients, with deep and harmonised phenotypic and genetic characterisation, are expected to be instrumental to improve our understanding of the genetic basis and pathophysiology of this intriguing vascular disease.

Keywords: PHACTR1; cervical artery dissection; fibromuscular dysplasia; genetic association; non atherosclerotic vascular stenosis; spontaneous coronary arteries dissection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Example of familial FMD from Belgian Multicentric FMD Cohort (BEL-FMD). Patient II.2 came to clinical attention at the age of 64 years for de novo arterial hypertension. The abdominal Computed Tomography Angiogram showed an aspect compatible with multifocal FMD of both renal arteries, significant on the right side. She underwent right percutaneous transluminal renal angioplasty (PTRA), and the hypertensive crises regressed. Patient II.4 was hypertensive from the age of 53 years and was referred at the age of 59 years for worsening of blood pressure control, associated to decreased renal function. Abdominal Magnetic Resonance Angiography (MRA) showed mild irregularities suggestive of FMD in the right renal artery, in the absence of significant stenosis. Patient II.6 came to clinical attention at the age of 58 years for renal asymmetry (kidney length: 9.5 cm on the right side vs. 12 cm on the left). The abdominal MRA identified a focal stenosis of 70% of the right renal artery. Patient II.6 underwent renal arteriography, which disclosed an irregular aspect of the arterial wall on the left side and only a 30% stenosis on the right side. Notably, none of these three patients had lesions of cervico-cephalic or others vascular beds. Estimated Glomerular Filtration Rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD) equation.
Figure 2
Figure 2
Association of rs9349379 locus with PHACTR1 and Endothelin-1 expression, cardio- and cerebrovascular diseases [46,51].

References

    1. Persu A., Giavarini A., Touzé E., Januszewicz A., Sapoval M., Azizi M., Barral X., Jeunemaitre X., Morganti A., Plouin P.F., et al. European consensus on the diagnosis and management of fibromuscular dysplasia. J. Hypertens. 2014;32:1367–1378. doi: 10.1097/HJH.0000000000000213. - DOI - PubMed
    1. Sharma A.M., Kline B. The United States registry for fibromuscular dysplasia: New findings and breaking myths. Tech. Vasc. Interv. Radiol. 2014;17:258–263. doi: 10.1053/j.tvir.2014.11.007. - DOI - PubMed
    1. Olin J.W., Froehlich J., Gu X., Bacharach J.M., Eagle K., Gray B.H., Jaff M.R., Kim E.S., Mace P., Matsumoto A.H., et al. The United States registry for fibromuscular dysplasia: Results in the first 447 patients. Circulation. 2012;125:3182–3190. doi: 10.1161/CIRCULATIONAHA.112.091223. - DOI - PubMed
    1. Plouin P.-F., Baguet J.-P., Thony F., Ormezzano O., Azarine A., Silhol F., Oppenheim C., Bouhanick B., Boyer L., Persu A., et al. High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: The ARCADIA registry (Assessment of Renal and Cervical Artery Dysplasia) Hypertension. 2017;70:652–658. doi: 10.1161/HYPERTENSIONAHA.117.09539. - DOI - PubMed
    1. Olin J.W., Gornik H.L., Bacharach J.M., Biller J., Fine L.J., Gray B.H., Gray W.A., Gupta R., Hamburg N.M., Katzen B.T., et al. Fibromuscular dysplasia: State of the science and critical unanswered questions: A scientific statement from the American Heart Association. Circulation. 2014;129:1048–1078. doi: 10.1161/01.cir.0000442577.96802.8c. - DOI - PubMed

LinkOut - more resources